Neutrophils are the immune system’s rapid-response force, and their primary function is to find, engulf, and destroy invading microorganisms before an infection can take hold. They are the most abundant white blood cells in your bloodstream, and they are almost always the first immune cells to arrive at a wound or site of infection. But “first responder” only scratches the surface. Research over the past two decades has revealed that neutrophils also help regulate inflammation, communicate with other immune cells, contribute to tissue repair, and even participate in anti-tumor responses. Their versatility comes with a tradeoff: when neutrophils act too aggressively or in the wrong context, they can damage your own tissues and drive serious disease.
How Neutrophils Get Where They Are Needed
Your bone marrow produces neutrophils continuously. Under normal conditions, this production keeps pace with the cells’ short lifespan, which is typically measured in hours to a day or two once they enter the bloodstream. During an acute infection or significant inflammation, demand for neutrophils spikes, and the bone marrow shifts into a higher gear through a process called emergency granulopoiesis, rapidly accelerating neutrophil generation to replenish the supply being consumed at the site of trouble.1PubMed Central. Regulation of emergency granulopoiesis during infection
Getting from the bloodstream into infected tissue is a multi-step process often described as a cascade. Neutrophils first make loose contact with the inner lining of blood vessel walls through molecules called selectins, which act like molecular speed bumps. This contact causes the neutrophils to slow down and roll along the vessel wall. Rolling gives them time to detect chemical alarm signals from the infected tissue, which triggers a firmer grip through another set of adhesion molecules called integrins. Once firmly attached, the neutrophil stops and begins squeezing through the vessel wall.2PubMed Central. Mechanisms and consequences of neutrophil interaction with the endothelium The squeeze itself is not simple: the neutrophil must pass through the endothelial cell layer, then navigate through a sheath of support cells and a basement membrane beneath the vessel, each step involving its own set of adhesive interactions.3Journal of Innate Immunity. Neutrophil Transmigration: Emergence of an Adhesive Cascade within Venular Walls
Killing Pathogens Up Close
Once a neutrophil reaches the site of infection, its primary weapon is phagocytosis: physically engulfing a bacterium, fungus, or other pathogen into an internal compartment called a phagosome. The phagosome then matures into a hostile environment designed to destroy whatever is trapped inside.4PubMed. Phagocytosis by neutrophils Neutrophils handle this differently from other phagocytes like macrophages. Rather than slowly acidifying the compartment, neutrophils rapidly dump the contents of preformed granules into the phagosome, flooding it with antimicrobial proteins and enzymes.5Journal of Leukocyte Biology. Phagosome dynamics during phagocytosis by neutrophils
Those granules are a defining feature of neutrophil biology. Neutrophils carry four distinct types, and they release them in a specific order as they move from the bloodstream toward the infection. Secretory vesicles go first, helping the neutrophil exit the blood vessel. Specific granules and gelatinase granules come next, aiding migration through tissue and beginning to create an antimicrobial zone. Last come the azurophilic granules, which deliver the most potent killing molecules directly into phagosomes and the surrounding environment.6PubMed. Armed for destruction: formation, function and trafficking of neutrophil granules
Alongside granule contents, neutrophils unleash a burst of reactive oxygen species, sometimes called the respiratory burst. An enzyme complex called NADPH oxidase assembles on the phagosome membrane and pumps out superoxide, which gives rise to a cascade of other toxic oxygen-derived molecules. This chemical assault is devastating to most bacteria.7PubMed. Priming of the neutrophil respiratory burst: role in host defense and inflammation The oxidase does not always fire at full power immediately. Neutrophils can be “primed” by initial signals, meaning a small exposure to bacterial products or inflammatory molecules puts them on alert so that a second signal triggers a much larger burst of reactive oxygen species.8PubMed Central. Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance
Neutrophil Extracellular Traps
Phagocytosis is not the only trick in a neutrophil’s arsenal. Under certain conditions, neutrophils can expel their own DNA outward in web-like structures called neutrophil extracellular traps, or NETs. These strands of modified chromatin are studded with antimicrobial proteins from the cell’s granules and cytoplasm, creating a sticky mesh that can snare and kill bacteria, fungi, and even some parasites in the space outside the cell.9PubMed Central. NETosis: Molecular Mechanisms, Role in Physiology and Pathology The process, called NETosis, typically requires the same NADPH oxidase that powers the respiratory burst, linking both weapons to the same enzymatic machinery.
NETs are effective against pathogens, but they come with risks. The same DNA-and-protein meshwork that traps bacteria can also abnormally activate blood clotting pathways, contributing to the formation of dangerous clots.10PubMed Central. Impact of Neutrophil Extracellular Traps on Thrombosis Formation: New Findings and Future Perspective This connection between NETs and thrombosis has drawn intense research interest, particularly in conditions like sepsis and severe COVID-19, where both runaway inflammation and clotting occur simultaneously.
How Inflammation Winds Down
An immune response that never stops would be almost as dangerous as the infection itself. Neutrophils are built with a short fuse by design: they are programmed to undergo apoptosis, a form of controlled cell death, relatively quickly after activation. Once a neutrophil dies this way, macrophages swallow the remains in a cleanup process called efferocytosis. This is not just waste disposal. When macrophages engulf apoptotic neutrophils, it actively flips the macrophages into an anti-inflammatory mode, dampening further immune activation and preventing the dead neutrophils from rupturing and spilling their toxic contents into tissue.11PubMed Central. Clearance of apoptotic neutrophils and resolution of inflammation When this process is disrupted experimentally, inflammation lingers and resolves poorly.12PubMed. The pro-apoptotic ARTS protein induces neutrophil apoptosis, efferocytosis, and macrophage reprogramming to promote resolution of inflammation
Neutrophils themselves contribute to the off-switch through a change in the chemical signals they produce. Early in inflammation, neutrophils generate lipid molecules that amplify the immune response and attract more immune cells. As the response progresses, the same cells begin producing a different class of lipid mediators that actively halt further neutrophil recruitment and promote tissue repair.13PubMed. Lipid mediator class switching during acute inflammation: signals in resolution This shift, called lipid-mediator class switching, means neutrophils help build the inflammation and then help dismantle it.14PubMed Central. Lipid mediators in the resolution of inflammation
When Neutrophils Do More Harm Than Good
The same destructive firepower that makes neutrophils effective against bacteria can devastate your own tissue if the response gets out of hand. Acute respiratory distress syndrome, or ARDS, is one of the clearest examples. In ARDS, massive numbers of activated neutrophils pour into the lungs, releasing granule contents and forming NETs that damage the delicate air sacs. Neutrophil counts in the lungs correlate with disease severity.15PubMed Central. Understanding the role of neutrophils in acute respiratory distress syndrome When ARDS is triggered by sepsis, the interaction between neutrophils and the cells lining blood vessels becomes a central driver of lung injury.16PubMed Central. Unraveling the deadly dance: endothelial cells and neutrophils in sepsis-induced acute lung injury/acute respiratory distress syndrome
Beyond ARDS, excessive or misdirected neutrophil activity plays a role in a range of conditions. Autoimmune diseases like rheumatoid arthritis and vasculitis involve neutrophil-mediated tissue damage. Gout flares are driven in part by neutrophils swarming into joints in response to uric acid crystals. Even heart attacks involve neutrophils that rush into oxygen-starved cardiac tissue and can worsen the damage during what is called reperfusion injury. In each case, the core problem is the same: the neutrophil’s destructive toolkit, evolved to kill microorganisms, is being turned against the body’s own cells.
What Happens When You Do Not Have Enough Neutrophils
Neutropenia, a shortage of circulating neutrophils, provides a natural experiment showing just how essential these cells are. The infection risk climbs steeply as the count drops, and severe neutropenia puts a person at risk for infections from organisms that normally live harmlessly on your skin and mucous membranes.17PubMed. Neutropenia: causes and consequences The risk is directly tied to both how low the count goes and how long it stays there.18PubMed. Neutropenia: etiology and pathogenesis
Chemotherapy is the most common cause of transient neutropenia, because the drugs that kill rapidly dividing cancer cells also suppress the bone marrow’s ability to churn out neutrophils. This is why fever in a chemotherapy patient is treated as a medical emergency: without neutrophils, even a minor bacterial incursion can quickly become life-threatening. Congenital forms of neutropenia also exist, caused by inherited defects in the bone marrow’s production machinery, and people with these conditions often need lifelong treatment with growth factors that stimulate neutrophil production.
Roles That Go Beyond Killing Bacteria
For decades, neutrophils were treated as simple, disposable attack cells. That picture has changed substantially. One of the more surprising findings is that neutrophils can function as antigen-presenting cells, a job traditionally associated with dendritic cells and macrophages. Research showed that human neutrophils exposed to specific viral proteins could present those proteins to memory T cells in a way that depended on the same molecular machinery used by professional antigen presenters.19PubMed Central. Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo Given how numerous neutrophils are, even a modest ability to present antigens could meaningfully influence adaptive immune responses.
Neutrophils also turn out to have a hand in tissue repair. They are the first immune cells to encounter an implanted biomaterial or a wound site, and they secrete enzymes that remodel the surrounding tissue matrix and promote the growth of new blood vessels, a process called angiogenesis.20PubMed. Neutrophils in Biomaterial-Guided Tissue Regeneration: Matrix Reprogramming for Angiogenesis The same cells that destroy tissue during runaway inflammation can, under the right circumstances, help rebuild it. Understanding how to tip the balance toward the repair side is an active area of bioengineering research, particularly for designing implants and scaffolds that heal well.
Neutrophils and Cancer
The relationship between neutrophils and tumors turns out to be complicated and context-dependent. Tumor-associated neutrophils can take on different personalities depending on the signals they receive from the tumor environment. Research has identified what are sometimes called anti-tumor (“N1”) and pro-tumor (“N2”) phenotypes. The molecule TGF-beta, which is abundant in many tumors, appears to push neutrophils toward a pro-tumor state. When TGF-beta signaling was experimentally blocked, the neutrophils that infiltrated the tumor became more cytotoxic to cancer cells, produced more inflammatory signals, and helped suppress tumor growth.21PubMed Central. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN
The cancer connection goes even further. Experiments with a compound called beta-glucan, found naturally in fungal cell walls, showed that training the innate immune system could reprogram neutrophil production in the bone marrow itself, shifting the resulting neutrophils toward an anti-tumor phenotype. This effect depended on interferon signaling and did not require the adaptive immune system at all.22Cell. Trained Immunity Enhances Anti-tumor Immunity by Remodeling Granulopoiesis and Neutrophil Response The idea that you could potentially retrain the body’s neutrophil factory to churn out cancer-fighting cells is early-stage science, but it has generated real excitement.
Trained Immunity and Neutrophil Memory
The beta-glucan experiments point to a broader concept that has reshaped how immunologists think about innate immune cells. Traditional teaching held that only the adaptive immune system (T cells and B cells) could remember past infections and mount stronger responses the second time. But a growing body of work shows that innate immune cells, including neutrophils and their precursors, can undergo lasting changes in their gene activity after certain exposures, a phenomenon called trained immunity.23PubMed Central. The role of neutrophils in trained immunity
Trained immunity does not work the way T-cell memory does. There is no antigen-specific receptor being selected and expanded. Instead, the changes are epigenetic, meaning the DNA sequence stays the same but the way genes are read and activated shifts in durable ways. A neutrophil precursor in the bone marrow that has been exposed to certain microbial signals may produce daughter cells that are more reactive, more inflammatory, or more cytotoxic than untrained cells. This can be beneficial in fighting infections or cancer, but it also has a potential downside: if trained immunity makes neutrophils chronically hyperactive, it could worsen inflammatory diseases.
How Bacteria Fight Back
The evolutionary pressure that neutrophils exert on bacteria has led many pathogens to develop sophisticated countermeasures. Some bacteria produce molecules that interfere with neutrophil recruitment, preventing the cells from reaching the infection site in the first place. Others block phagocytosis, either by disguising themselves with capsules that neutrophils cannot grip or by injecting toxins that paralyze the cell’s engulfment machinery. Still others survive inside the phagosome by neutralizing reactive oxygen species or preventing granule fusion. Some pathogens can even manipulate neutrophil apoptosis, either accelerating it to kill the neutrophil before it can do its job or delaying it to use the neutrophil as a hiding place.24PubMed Central. Neutrophils and Bacterial Immune Evasion
Staphylococcus aureus is a textbook example. It produces a cocktail of molecules targeting almost every step of neutrophil function: proteins that block complement-mediated recognition, toxins that punch holes in neutrophil membranes, and enzymes that break down NETs. The ongoing arms race between neutrophils and pathogens like Staph has been running for hundreds of millions of years, and neither side has won decisively.
Neutrophils on a Clock
Your neutrophil count does not stay constant throughout the day. These cells follow a circadian rhythm, with significant swings in both their numbers and their functional properties over a 24-hour cycle. Freshly released neutrophils from the bone marrow behave differently from aged ones that have been circulating for hours, and the proportion of fresh versus aged cells shifts predictably with the time of day.25PubMed Central. Circadian Features of Neutrophil Biology This matters clinically: the timing of certain inflammatory events, like heart attacks occurring disproportionately in the morning hours, may be partly linked to daily fluctuations in neutrophil reactivity. It also affects lab results. A blood count drawn in the early morning may look meaningfully different from one drawn in the evening, not because anything changed medically but because your neutrophils are on a schedule.
Neutrophil-Inspired Drug Delivery
One of the more creative applications of neutrophil biology is in drug delivery. Researchers have developed nanoparticles coated with real neutrophil cell membranes. Because the nanoparticle surface carries the same proteins as a living neutrophil, the body’s immune surveillance tends to leave it alone, and it naturally homes in on inflamed tissue the same way a real neutrophil would.26PubMed Central. Neutrophil membrane-coated nanoparticles for targeted therapy These neutrophil-membrane-coated nanoparticles have shown promise in animal models for delivering drugs directly to sites of inflammation, tumors, and even brain injuries that would normally be shielded by the blood-brain barrier.
Interestingly, even without any drug cargo, the membrane coating itself appears to have anti-inflammatory effects. The neutrophil surface proteins on the nanoparticle can absorb inflammatory signals and compete with real neutrophils for binding to the vessel wall, effectively soaking up some of the chemical alarm signals that drive excessive inflammation.27PubMed. Anti-inflammatory mechanisms of neutrophil membrane-coated nanoparticles without drug loading The technology is still preclinical, but it illustrates how thoroughly researchers now understand neutrophil surface biology, well enough to copy it onto a synthetic particle and put it to therapeutic use.